Audeh, M W <br/><br/>
MDS and secondary AML: an evolutionary perspective.  [electronic resource] 

 -  Cancer treatment and research  2001 
 - 267-78 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0927-3042 
<br/><br/><label>Standard No.: </label>10.1007/978-1-4615-1463-3_14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Antineoplastic Agents--adverse effects<br/>Biotransformation--genetics<br/>Bone Marrow Cells--pathology<br/>Cell Survival<br/>Clone Cells--pathology<br/>Disease Progression<br/>Genetic Predisposition to Disease<br/>Genetic Variation<br/>Humans<br/>Infections--complications<br/>Leukemia, Myeloid--etiology<br/>Models, Biological<br/>Myelodysplastic Syndromes--drug therapy<br/>Neoplastic Stem Cells--pathology<br/>Preleukemia--drug therapy<br/>Selection, Genetic<br/>Xenobiotics--adverse effects